Fujitsu and Tokyo Shinagawa Hospital to develop an AI-based technology to facilitate the diagnosis of COVID-19 pneumonia

Fujitsu and Tokyo Shinagawa Hospital today announced the launch of a joint R&D project for AI technology to support diagnostic imaging via chest CT (Computed Tomography), which represents a promising candidate for the effective diagnosis of COVID-19 pneumonia. The newly-proposed technology supports doctors performing diagnostic imaging on patients suspected of having COVID-19 pneumonia, presenting the likelihood of infection through a numerical, three-dimensional visualization of the spread of shadows in the lungs using chest CT imaging.

READ  Mitsubishi Electric’s Mobile Mapping System and AI to hasten autonomous driving

Applying AI to this analysis could significantly reduce the burden on doctors who diagnose COVID-19 pneumonia by automating a process that normally demands the visual confirmation of hundreds of chest CT images per patient. Fujitsu and Tokyo Shinagawa Hospital anticipate that the system will deliver early detection of cases of COVID-19 pneumonia based on chest CT image findings, even in cases in which the possibility of infection is determined to be low upon initial examination. This joint research will enhance AI diagnostic support technology for novel coronavirus pneumonia. .Fujitsu ultimately aims to commercialize the technology as a healthcare solution for frontline medical professionals.

READ  Fujitsu Delivers Complete Set of 5G Base Station Products to NTT DoCoMo for Commercial 5G Service